Diagnostic value of partial exome sequencing in developmental disorders
暂无分享,去创建一个
A. Rump | B. Klink | S. Markus | A. Tzschach | K. Hackmann | M. von der Hagen | J. Lemke | N. Di Donato | Luisa Mackenroth | J. Schallner | B. Novotna | E. Schrock | L. Gieldon | A. Jahn | Franziska Kuhlee | J. Wagner | J. Porrmann | S. Weidensee | A. Kahlert | Charlotte Soerensen
[1] S. Pajusalu,et al. Large gene panel sequencing in clinical diagnostics—results from 501 consecutive cases , 2018, Clinical genetics.
[2] Daniele Merico,et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test , 2017, Genetics in Medicine.
[3] Renzo Guerrini,et al. Lissencephaly: Expanded imaging and clinical classification , 2017, American journal of medical genetics. Part A.
[4] M. State,et al. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield , 2017, Molecular Psychiatry.
[5] Deciphering Developmental Disorders Study,et al. Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.
[6] Joan,et al. Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.
[7] W. Chung,et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.
[8] R. Horvath,et al. Novel homozygous RARS2 mutation in two siblings without pontocerebellar hypoplasia – further expansion of the phenotypic spectrum , 2016, Orphanet Journal of Rare Diseases.
[9] M. Roselló,et al. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing , 2016, Journal of Medical Genetics.
[10] R. Płoski,et al. Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations , 2016, Journal of Translational Medicine.
[11] R. Guerreiro,et al. RARS2 mutations in a sibship with infantile spasms , 2016, Epilepsia.
[12] C. Pérez-Cerdá,et al. Molecular diagnosis of glycogen storage disease and disorders with overlapping clinical symptoms by massive parallel sequencing , 2016, Genetics in Medicine.
[13] A. Rump,et al. Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt , 2016, Journal of Medical Genetics.
[14] F. Pidcock,et al. Functional outcomes in Rett syndrome , 2016, Brain and Development.
[15] Francesca Forzano,et al. A specific mutation in TBL1XR1 causes Pierpont syndrome , 2016, Journal of Medical Genetics.
[16] W. Chung,et al. Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.
[17] Gert Matthijs,et al. Guidelines for diagnostic next-generation sequencing , 2015, European Journal of Human Genetics.
[18] Alessandra Renieri,et al. Targeted Next‐Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability , 2015, Human mutation.
[19] Saudi Mendeliome Group. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases , 2015, Genome Biology.
[20] Mohammed Alhashem,et al. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases , 2015, Genome Biology.
[21] Emil Alexov,et al. Structural, Dynamical, and Energetical Consequences of Rett Syndrome Mutation R133C in MeCP2 , 2015, Comput. Math. Methods Medicine.
[22] Alejandro Sifrim,et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.
[23] Steven P. Angus,et al. Redefining the MED13L syndrome , 2015, European Journal of Human Genetics.
[24] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[25] Tomas W. Fitzgerald,et al. Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.
[26] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[27] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[28] J. Moeschler,et al. Comprehensive Evaluation of the Child With Intellectual Disability or Global Developmental Delays , 2014, Pediatrics.
[29] Magalie S Leduc,et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. , 2013, The New England journal of medicine.
[30] G. Houge,et al. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability , 2013, European Journal of Human Genetics.
[31] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[32] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[33] S. Gallati,et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders , 2012, Epilepsia.
[34] B. Burton,et al. The Coffin–Siris syndrome: A proposed diagnostic approach and assessment of 15 overlapping cases , 2012, American journal of medical genetics. Part A.
[35] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[36] Christian Gilissen,et al. A de novo paradigm for mental retardation , 2010, Nature Genetics.
[37] H. Ropers. Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.
[38] K. Kernohan,et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. , 2010, Developmental cell.
[39] R. Hennekam,et al. Etiology of mental retardation in children referred to a tertiary care center: a prospective study. , 2005, American journal of mental retardation : AJMR.
[40] J. Goodship,et al. Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients With Congenital Heart Defect (Transposition of the Great Arteries) , 2003, Circulation.
[41] S Schwartz,et al. Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. , 1997, American journal of medical genetics.
[42] F. Baas,et al. RARS2 Mutations: Is Pontocerebellar Hypoplasia Type 6 a Mitochondrial Encephalopathy? , 2017, JIMD reports.
[43] Steven P. Angus,et al. Rede fi ning the MED 13 L syndrome , 2015 .
[44] G. Arbanas. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .
[45] H. Ropers,et al. Genetics of recessive cognitive disorders. , 2014, Trends in genetics : TIG.